国家药物短缺:补救行政和立法倡议
Eli Y Adashi1, Daniel P O'Mahony2, I Glenn Cohen2
1From the Brown University; Brown University Library; Harvard Law School; and Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard University (EYA, DPO, IGC). Eli_Adashi@brown.edu.
Journal of the American Board of Family Medicine : JABFM
|November 19, 2025
概括
国家药物短缺威胁到患者护理和健康结果. 政策制定者必须采取行动,加强制药供应链,防止未来的药物短缺.
科学领域:
- 卫生政策 卫生政策
- 药品供应链管理 药品供应链管理
- 患者护理 患者护理
背景情况:
- 药物短缺是美国医疗保健的一个持续问题,COVID-19大流行严重恶化.
- 现有的联邦努力提高制药供应链的弹性是不够的.
- 药物短缺扰乱了患者护理,危及了国家健康.
研究的目的:
- 审查来自第118届国会和拜登政府的关键行政和立法倡议,旨在防止未来的药物短缺.
- 强调119届国会和下一届总统政府继续采取政策行动的必要性.
主要方法:
- 审查拟议的联邦行政和立法倡议.
- 对加强国家药物供应链的努力进行分析.
主要成果:
- 以往解决药物短缺问题的举措并没有完全成功.
- 第118届国会和拜登政府提出了几项措施,但问题仍然存在.
- 未来的第119届国会和政府需要采取进一步行动.
结论:
- 缓解国家药物短缺需要持续和有效的政策干预.
- 解决药物短缺问题对于确保护理的连续性和保护国家健康至关重要.
- 决策者需要采取紧急行动,改革制药供应链,防止未来的短缺.
相关概念视频
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Prescription, Nonprescription and Orphan Drugs
1.1K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K
Drug Control Governance: Regulatory Bodies and Their Impact
466
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
466
Drug Products: Biologics, Biosimilars and Interchangeables
221
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
221
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
160
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
160
Drug Nomenclature
3.0K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.0K


